Form 4: Patricia Hemingway Hall Receives RSU Grant at Cardinal

Director Patricia Hemingway Hall was granted 381 restricted stock units following her appointment as Chair of the Board.

Summary

• Director Patricia Hemingway Hall acquired 381 restricted stock units (RSUs) of Cardinal Health Inc. (CAH).
• The grant was issued in connection with her elevation to Chair of the Board, which became effective on March 20, 2026.
• The transaction was valued at $207.83 per share, based on the closing price on the date of her appointment.
• Following this transaction, the reporting person holds a total of 28,645 shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard corporate governance and compensation practices.

Positives

• The grant aligns the interests of the new Chair of the Board with those of shareholders through equity ownership.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine disclosure of director equity compensation.

Management Comments

• The grant of RSUs is specifically linked to the reporting person's elevation to the role of Chair of the Board.

Industry Context

StockSavvy.ai notes that equity-based compensation for board leadership is standard practice in the healthcare distribution sector to ensure long-term alignment with corporate governance objectives.

Comparison to Industry Standards

• The use of RSUs for board members is consistent with compensation structures at peer companies like McKesson and AmerisourceBergen (Cencora).
• The disclosure follows standard SEC Section 16(a) reporting requirements for executive and director equity changes.

Corporate Governance

Stakeholder Impact

• Shareholders may view the alignment of the new Chair's compensation with equity performance as a positive governance signal.

Next Steps

• No further actions required by the reporting person regarding this specific transaction.

Key Dates

Keywords

Cardinal Health, CAH, Form 4, Insider Trading, Director Compensation, Equity Grant